Skip to main content
OpenTrials
Completed

NCT Number: NCT04683536

Bakircay University Cigli Training and Research Hospital

The aim of the study is to investigate the oncological outcomes of obturator nerve blockade in patients with lateral wall localized non-muscle invasive bladder cancer

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bladder Cancer Carcinoma Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Non-Muscle Invasive Bladder Neoplasms Urinary Bladder Diseases Urinary Bladder Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Sex eligibility

All sexes

Study type

Observational

About this study

Patient divided into two group.First group includes patients underwent TUR-BT under only spinal anesthesia and second group includes patients underwent TUR-BT under spinal anesthesia combined with ultrasound guided obturator nerve blockade.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with lateral wall localized non muscle invasive bladder cancer

Exclusion criteria

  • history of previous TUR-BT
  • diagnosis of non-urothelial carcinoma
  • coagulopathy
  • history of allergic reaction to the local anesthtetic agent
  • presence of muscle-invasive bladder cancer
  • history of chemotherapy or radiotherapy before TUR-BT
  • precence of variant histopathology
  • using bipolar energy for the resection of bladder tumor
  • presence of concomittant upper urothelial tract urothelial carcinoma
  • patients with the neuromusculer disease
  • pregnancy
  • history of medication effecting immune system

Treatment and study plan

Obturator nerve blockade

Procedure

We performed spinal anesthesia combined with ultrasound guided obturator nerve blockade according to the localization of bladder cancer in patients with lateral wall localized non-muscle invasive bladder cancer

Primary outcomes

  1. Oncological outcomes

    Time frame: 5 year

    Reccurens or progression of tumor was recorded

Secondary outcomes

  1. Complications

    Time frame: 5 years

    Complications during surgery was recorded

Sponsors and collaborators

Lead sponsor

Recep Tayyip Erdogan University Training and Research Hospital

Other

Registry information

Acronym: BUCEAH

Important dates

Study start
2015
Primary completion
2020
Study completion
2020
First posted
Dec 24, 2020
Registry last updated
Dec 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.